RT Journal Article
SR Electronic
T1 Late Breaking Abstract - Associations of intensity of ventilation with mortality in COVID–19 patients with ARDS
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA3780
DO 10.1183/13993003.congress-2021.PA3780
VO 58
IS suppl 65
A1 Michiel Schuijt
A1 David Van Meenen
A1 Ignacio Martin–loeches
A1 Guido Mazzinari
A1 Marcus Schultz
A1 Frederique Paulus
A1 Ary Serpa Neto
YR 2021
UL http://erj.ersjournals.com/content/58/suppl_65/PA3780.abstract
AB Background: There is scant information about intensity of ventilation and mortality in COVID–19 patients with ARDS.Aim: To investigate the association between exposure to different levels of driving pressure (ΔP) and mechanical power (MP) with mortality in these patientsMethods: Multicenter observational study in 734 COVID–19 patients with ARDS. ΔP and MP were calculated at fixed time points during the first 4 calendar days of ventilation using granular ventilation data. The primary endpoint was 28–day mortality. To assess the effects of time–varying exposure, Bayesian joint models adjusted for confounders were used.Results: In the first 28 days, 214 (29.2%) patients died. A significant increase in the hazard of death was associated with each increment in ΔP (HR 1.04 [95%–CrI 1.01–1.07]; P = 0.010) and in MP (HR 1.12 [95%–CrI 1.01–1.36]; P = 0.018). Cumulative exposure to higher levels of ΔP or MP were both associated with higher risk for 28–day mortality (Figure 1).Conclusions: Cumulative exposure to higher intensities of ventilation in COVID–19 patients with ARDS is associated with increased risk of 28–day mortality. Limiting exposure to high ΔP or MP has the potential to improve survival in these patients. Figure 1. Association Between Intensity of Exposure to Higher Driving Pressure and Mechanical Power and 28-Day MortalityFootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3780.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).